Sentence examples for trial to define from inspiring English sources

This fact highlights the importance of completion of currently ongoing trials for example, CREST (Carotid Revascularization Endarterectomy versus Stent Trial) and ACT 1 (Asymptomatic Carotid Stenosis, Stenting versus Endarterectomy Trial)—to define the best contemporary carotid revascularisation strategy.

We conducted a phase 2 trial to determine if a canarypox vaccine candidate (vCP1452) administered with rgp120 subunit protein would "qualify" for a trial to define a correlate of efficacy.

Therefore, in our study, a neutral rotational position was defined as a knee angle five frames before foot contact, while others most often used a standing trial to define the neutral position (Ristanis et al., 2006, Tsarouhas et al., 2010, Tsarouhas et al., 2011, Webster et al., 2010).

First, the study by Opal et al was a secondary analysis of a population of septic patients selected from the placebo arm of a phase III randomized controlled trial to define the safety and efficacy of recombinant human interleukin 1 receptor antagonist in patients with sepsis [36].

It is a major challenge in any non-medical trial to define a proper control group.

20 trial, to define the predictive value of AUCHD-MTX and to identify clinical and therapeutic variables that could be manipulated to improve MTX efficacy in patients with PCNSL.

For each unit, we calculated mean FR over trials to define a PSTH/PMTH over time.

Imaging will play a crucial role in future clinical trials to define eligibility of potential participants and to monitor safety during the course of these studies.

In particular, there is an urgent need for high-quality descriptive research, including prospective cohort studies, as well as randomized controlled trials to define optimal management strategies.

We describe the steps in health technology assessment and the potential design of preclinical and clinical trials to define the role of proton therapy in the future.

Evaluation of molecular prognostic markers should be incorporated into phase II and III trials to define their roles in clinical outcome.